{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:36:11Z","timestamp":1789781771091,"version":"4.0.1"},"reference-count":16,"publisher":"Bioscientifica","license":[{"start":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T00:00:00Z","timestamp":1515110400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/deed.en_GB"}],"content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,1,5]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Methimazole (MMI) and propylthiouracil (PTU) are widely used antithyroid drugs (ATD) that have been approved for the treatment of hyperthyroidism. Hepatotoxicity may be induced by these drugs, though they exert dissimilar incidence rates of hepatotoxicity and, possibly, with different underlying pathogenic mechanisms. We report the case of a 55-year-old woman with no relevant medical history diagnosed with hyperthyroidism due to Graves\u2019 disease, who developed two episodes of acute hepatitis concurrent with the consecutive administration of two different ATDs, first MMI and then PTU. Given the impossibility of administering ATDs, it was decided to perform a total thyroidectomy because the patient was found to be euthyroid at that point. Pathological anatomy showed diffuse hyperplasia and a papillary thyroid microcarcinoma of 2\u2009mm in diameter. Subsequent clinical check-ups were normal. This case suggests the importance of regular monitoring of liver function for hyperthyroid patients. Due to the potential severity of this side effect, it is recommended to determine baseline liver function prior to initiation of treatment.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Learning points:<\/jats:title>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>We present a rare case of two acute hepatitis episodes concurrent with two different consecutive ATD therapies.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Our results highlight the relevance of a liver function monitoring during the treatment with MMI or PTU.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>A baseline assessment of the liver function before starting an ATD treatment should be recommendable.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>","DOI":"10.1530\/edm-17-0173","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T01:37:22Z","timestamp":1515375442000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":6,"title":["Hepatotoxicity in hyperthyroid patient after consecutive methimazole and propylthiouracil therapies"],"prefix":"10.1530","volume":"2018","author":[{"given":"Fernando","family":"Gomez-Peralta","sequence":"first","affiliation":[{"name":"1Endocrinology and Nutrition UnitHospital General de Segovia, Segovia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Velasco-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"2Department of Internal MedicineHospital General de Segovia, Segovia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Abreu","sequence":"additional","affiliation":[{"name":"1Endocrinology and Nutrition UnitHospital General de Segovia, Segovia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Cepeda","sequence":"additional","affiliation":[{"name":"2Department of Internal MedicineHospital General de Segovia, Segovia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Fern\u00e1ndez-Puente","sequence":"additional","affiliation":[{"name":"2Department of Internal MedicineHospital General de Segovia, Segovia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"ref151","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2006-2135","article-title":"Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves\u2019 disease","volume":"92","year":"2007","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref21","first-page":"1","article-title":"An overview on the proposed mechanisms of antithyroid drugs-induced liver injury","volume":"5","year":"2015","journal-title":"Advanced Pharmaceutical Bulletin"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1001\/jama.2015.16535","article-title":"Management of Graves disease: a review","volume":"314","year":"2015","journal-title":"JAMA"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"21","year":"2011","journal-title":"Thyroid"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1517\/14740338.2014.953796","article-title":"Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity","volume":"13","year":"2014","journal-title":"Expert Opinion on Drug Safety"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1001\/jama.2015.16535","article-title":"Management of Graves disease: a review","volume":"314","year":"2015","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bcp.12336","article-title":"Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study","volume":"78","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"21","year":"2011","journal-title":"Thyroid"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bcp.12336","article-title":"Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study","volume":"78","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3350\/cmh.2014.20.3.237","article-title":"Factors affecting drug-induced liver injury: antithyroid drugs as instances","volume":"20","year":"2014","journal-title":"Clinical and Molecular Hepatology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3350\/cmh.2014.20.3.237","article-title":"Factors affecting drug-induced liver injury: antithyroid drugs as instances","volume":"20","year":"2014","journal-title":"Clinical and Molecular Hepatology"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1517\/14740338.2014.953796","article-title":"Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity","volume":"13","year":"2014","journal-title":"Expert Opinion on Drug Safety"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2006-2135","article-title":"Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves\u2019 disease","volume":"92","year":"2007","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref101","first-page":"1","article-title":"An overview on the proposed mechanisms of antithyroid drugs-induced liver injury","volume":"5","year":"2015","journal-title":"Advanced Pharmaceutical Bulletin"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2018\/1\/EDM17-0173.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2018\/1\/EDM17-0173.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:46:47Z","timestamp":1784555207000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,5]]},"references-count":16,"URL":"https:\/\/doi.org\/10.1530\/edm-17-0173","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,5]]}}}